Halozyme Therapeutics Competitors and Similar CompaniesClear all
Halozyme Therapeutics's competitors and similar companies include Blueprint Medicines, Agenus and Rakuten Medical.
 Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Blueprint Medicines Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. |  Rakuten Medical Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies. | |
Founding Date | Founding Date 1998 | Founding Date 2011 | Founding Date 1994 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations San Diego, US HQ | Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | Locations San Diego, US HQ Setagaya City, JP Amsterdam, NL Ecublens, CH Taipei, TW Taipei, TW San Mateo, US |
Employees | Employees 373157% increase | Employees 6552% increase | Employees 38927% decrease | Employees 1181% decrease |
Valuation ($) | Valuation ($) 6.4 b | Valuation ($) 5.3 b | Valuation ($) 96.2 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $1b (FY, 2024) | Revenue (est.) $508.8m (FY, 2024) | Revenue (est.) $156.3m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $159.4m (FY, 2024) | Cost of goods $20.2m (FY, 2024) | Cost of goods $3.1m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $855.9m (FY, 2024) | Gross profit $488.7m (FY, 2024) | Gross profit $153.2m (FY, 2023) | Gross profit N/A |
Net income | Net income $444.1m (FY, 2024) | Net income ($67.1m) (FY, 2024) | Net income ($257.4m) (FY, 2023) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 171.9m | Total funding raised $ 1.7b | Total funding raised $ 171.1m | Total funding raised $ 451.9m |
For sources of this data, please see the company profile
View Company Profiles
Blueprint Medicines
HQ
Cambridge, US
Employees
655↑ 2% increase
Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.
View companyAgenus
HQ
Lexington, US
Employees
389↓ 27% decrease
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View companyRakuten Medical
HQ
San Diego, US
Employees
118↓ 1% decrease
Rakuten Medical (formerly Rakuten Aspyrian) is a clinical stage biotechnology company developing tumor-targeted precision therapies.
View company